Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2018 3
2019 4
2020 6
2021 4
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
A parallel randomised controlled trial of the Hypoglycaemia Awareness Restoration Programme for adults with type 1 diabetes and problematic hypoglycaemia despite optimised self-care (HARPdoc).
Amiel SA, Potts L, Goldsmith K, Jacob P, Smith EL, Gonder-Frederick L, Heller S, Toschi E, Brooks A, Kariyawasam D, Choudhary P, Stadler M, Rogers H, Kendall M, Sevdalis N, Bakolis I, de Zoysa N. Amiel SA, et al. Nat Commun. 2022 Apr 28;13(1):2229. doi: 10.1038/s41467-022-29488-x. Nat Commun. 2022. PMID: 35484106 Free PMC article. Clinical Trial.
Developing a novel intervention for type 1 diabetes and disordered eating using a participatory action design process: Safe management of people with Type 1 diabetes and EAting Disorders studY (STEADY).
Zaremba N, Robert G, Allan J, Harrison A, Brown J, Konstantara E, Rosenthal M, Pillay D, Beckwith A, Treasure J, Hopkins D, Ismail K, Stadler M. Zaremba N, et al. Diabet Med. 2022 Apr;39(4):e14749. doi: 10.1111/dme.14749. Epub 2021 Dec 23. Diabet Med. 2022. PMID: 34821402
Metformin to reduce metabolic complications and inflammation in patients on systemic glucocorticoid therapy: a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2 trial.
Pernicova I, Kelly S, Ajodha S, Sahdev A, Bestwick JP, Gabrovska P, Akanle O, Ajjan R, Kola B, Stadler M, Fraser W, Christ-Crain M, Grossman AB, Pitzalis C, Korbonits M. Pernicova I, et al. Lancet Diabetes Endocrinol. 2020 Apr;8(4):278-291. doi: 10.1016/S2213-8587(20)30021-8. Epub 2020 Feb 25. Lancet Diabetes Endocrinol. 2020. PMID: 32109422 Clinical Trial.
Hypoglycaemia Awareness Restoration Programme for People with Type 1 Diabetes and Problematic Hypoglycaemia Persisting Despite Optimised Self-care (HARPdoc): protocol for a group randomised controlled trial of a novel intervention addressing cognitions.
Amiel SA, Choudhary P, Jacob P, Smith EL, De Zoysa N, Gonder-Frederick L, Kendall M, Heller S, Brooks A, Toschi E, Kariyawasam D, Potts L, Healy A, Rogers H, Sevdalis N, Stadler M, Qayyum M, Bakolis I, Goldsmith K. Amiel SA, et al. BMJ Open. 2019 Jun 16;9(6):e030356. doi: 10.1136/bmjopen-2019-030356. BMJ Open. 2019. PMID: 31209097 Free PMC article.
13 results